Global Lung Cancer Diagnostics Market Worth $30.84 Billion by 2030, Influenced by Advanced Imaging and Biomarker Testing
March 05, 2024 12:06 ET
|
Research and Markets
Dublin, March 05, 2024 (GLOBE NEWSWIRE) -- The "Lung Cancer Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis"...
Lung Cancer Screening Market Anticipated to Surge, Marking a Significant Growth by 2028, Reveals a Global Forecast Highlighting Industry Trends and Opportunities
January 29, 2024 06:59 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Lung Cancer Screening Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
Global Lung Cancer Diagnostics Strategic Research Report 2023: Imaging Tests Segment and US Leads, Molecular Tests Category and Asia-Pacific to Witness Growth
October 27, 2023 06:33 ET
|
Research and Markets
Dublin, Oct. 27, 2023 (GLOBE NEWSWIRE) -- The "Lung Cancer Diagnostics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Lung Cancer Diagnostics...
Lung Cancer Diagnostics Market to Reach US$ 26.3 Bn by End of 2031, as per TMR Report
February 22, 2023 06:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – The global Lung Cancer Diagnostics Market is likely to expand at a CAGR of 7.3% between...
Lung Cancer Diagnostics Market to Witness Healthy CAGR of 14.2% by 2030, Size, Share, Trends, Opportunities, Key Growth Drivers and Future Outlook
January 03, 2023 15:30 ET
|
Data Bridge Market Research
NEW YORK, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research completed a qualitative study titled "Lung Cancer Diagnostics Market" with 100+ market data tables, pie charts, graphs, and...
Lung Cancer Diagnostics Market Size [2022-2028] | Industry Size, Share, Growth & Forecast Analysis
March 13, 2022 05:12 ET
|
Fortune Business Insights
Pune, India, March 13, 2022 (GLOBE NEWSWIRE) -- The global lung cancer diagnostics market size is projected to experience dynamic expansion in the upcoming years owing to the increasing prevalence...
Biodesix Advances ORACLE Registry for Lung Nodule Cancer Test
October 30, 2018 08:27 ET
|
Biodesix, Inc.
Noninvasive Test to Rule Out Cancer Expected to Lower Patient Anxiety and Costs BOULDER, Colo., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Biodesix® today provided an update on the Observational Registry...
Study Published In Managed Care Regarding Prognostic and Cancer-Care Planning Value of Biodesix’s VeriStrat® Proteomic Test
September 20, 2017 11:17 ET
|
Biodesix, Inc.
BOULDER, Colo., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Findings published in the peer-reviewed journal Managed Care showed that prognostic information provided by the Biodesix® VeriStrat test can...
New Data Show Biodesix’s VeriStrat® Test is Cost-Saving, Improves Survival and Quality of Life in Advanced Lung-Cancer Patients
April 03, 2017 13:08 ET
|
Biodesix, Inc.
BOULDER, Colo., April 03, 2017 (GLOBE NEWSWIRE) -- Biodesix®, Inc. announced today new data demonstrating that use of the VeriStrat® test in patients with advanced non-small cell lung cancer (NSCLC)...